Bisirna Therapeutics is focused on advancing RNAi therapeutics, particularly in the development of oligonucleotide therapeutics for cardiovascular and metabolic diseases
Bisirna Therapeutics is focused on advancing RNAi therapeutics, particularly in the development of oligonucleotide therapeutics for cardiovascular and metabolic diseases.